FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical preparation for oral using comprising moxifloxacin or its salt, and/or hydrate, at least one binding agent, at least one accessory agent promoting to degradation, at least one lubricating agent and from 2.5% to 25% of lactose. The preparation is designated for control of bacterial infections in humans and animals and it exhibits high hardness and good release properties.
EFFECT: valuable pharmaceutical properties of preparation.
9 cl, 3 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
| COMPOSITIONS CONTAINING FINELY GROUND NEBIVOLOL | 1995 |
|
RU2137473C1 |
| IRBESARTAN-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2465900C2 |
| INJECTION MOXIFLOXACIN SOLUTION AND METHOD FOR ITS PREPARING | 2006 |
|
RU2314103C1 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING (VARIANTS) | 1992 |
|
RU2106145C1 |
| PHARMACEUTICAL PREPARATION, DISPERSIBLE PELLET, AND METHOD OF PRODUCTION THEREOF | 1995 |
|
RU2145850C1 |
| SOLID DOSAGE FORM OF PREPARATIONS OF MEMANTINE AND ITS SALTS | 2010 |
|
RU2483715C2 |
| METHOD FOR PREPARING SOLID, ORAL PHARMACEUTICAL FORMULATION | 2009 |
|
RU2493850C2 |
| ANTIBACTERIAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING IT | 2013 |
|
RU2561037C2 |
| METHOD FOR MAKING SOLID ORAL PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2379036C2 |
